Evidence map›Paper›PMID 22228418›Full record

ArticleTransplantation2012

Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning.

Hong Xu, Ziqiang Zhu, Yiming Huang, Larry D Bozulic, Lala-Rukh Hussain, Jun Yan, Suzanne T Ildstad

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Stem cell therapy to cure type 1 diabetes: from hype to hope.Stem cells translational medicine · 2013
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hong XuInstitute for Cellular Therapeutics, University of Louisville, Louisville, KY 40202-1760, USA.
Ziqiang Zhu
Yiming Huang
Larry D Bozulic
Lala-Rukh Hussain
Jun Yan
Suzanne T Ildstad
University of Louisville · US

Funding

Tolerance Induction to Islet TransplantsR01DK069766 · NIDDK · UNIVERSITY OF LOUISVILLE · PI ILDSTAD, SUZANNE T · 2005 to 2010
$1.6M
Mixed HSC Chimerism in Sensitized RecipientsR01HL063442 · NHLBI · UNIVERSITY OF LOUISVILLE · PI ILDSTAD, SUZANNE T · 2002 to 2005
$1.6M
NHLBI NIH HHS NIH 5RO1 HL063442NHLBI NIH HHS R01 HL063442NIDDK NIH HHS NIH R01 DK069766NIDDK NIH HHS R01 DK069766
6 · The paper itself

Abstract

backgroundMixed chimerism is an effective approach for tolerance induction in transplantation. Strategies to achieve mixed chimerism with relatively low toxicity have significantly expanded the clinical use of chimerism.

methodsAllogeneic bone marrow transplants were performed between B6 (H2(b)) and BALB/c (H2(d)) mice. Recipient B6 mice were nonmyeloablatively conditioned with anti-αβ-T-cell receptor, anti-CD154, or rapamycin alone or in different combinations. A total of 15 × 10(6) BALB/c bone marrow cells were transplanted after varying doses of cGy of total body irradiation.

resultsPretreatment of recipients with anti-CD154 and rapamycin with or without T-cell lymphodepletion reduced the total body irradiation requirement to 100 cGy for establishing stable mixed chimerism. The mixed chimeras accepted donor islet allografts long term. Lymphocytes from mixed chimeras did not respond to host or donor antigens, yet were reactive to major histocompatibility complex-disparate third-party alloantigens, demonstrating functional donor-specific T-cell tolerance. No antibodies against donor and host were detected in mixed chimeras, suggesting humoral tolerance. Mixed chimeras showed no cytotoxicity to donor cells, but a similar rapid killing rate for major histocompatibility complex disparate third-party B10.BR cells compared with T-cell-deficient and wild-type controls in in vivo cytotoxicity assays, suggesting donor-specific tolerance in the innate immune cells was achieved in mixed chimeras.

conclusionsMixed chimeras prepared with low-intensity nonmyeloablative conditioning exhibit systemic tolerance in innate immunity and tolerance in adaptive T- and B-cell immune responses.

Indexed as

Adaptive ImmunityImmune ToleranceImmunity, InnateTransplantation ConditioningAnimalsAntibodies, MonoclonalB-LymphocytesBone Marrow TransplantationCD40 LigandGraft RejectionGraft SurvivalImmunity, HumoralImmunosuppressive AgentsIslets of Langerhans TransplantationLymphocyte Culture Test, MixedLymphocyte DepletionAntibodies, MonoclonalCD40 LigandImmunosuppressive AgentsReceptors, Antigen, T-Cell, alpha-betaSirolimus

Identifiers

PMID22228418
PMCPMC3613854
OpenAlexW1988422119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.